Kurume, Japan

Kouichiro Kawano

This inventor holds 1 USPTO granted patent. Top assignees: Health Research, Inc., The University of Texas System. Active years: 2008.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kouichiro Kawano: Innovator in Immunogenic Peptide Design

Introduction

Kouichiro Kawano is a notable inventor based in Kurume, Japan. He has made significant contributions to the field of immunology, particularly in the design of immunogenic peptides. His work focuses on enhancing the immune response to antigens, which has important implications for vaccine development and cancer therapy.

Latest Patents

Kawano holds a patent for a method for identifying and designing immunogenic peptides. This invention provides a systematic approach for identifying peptides that can increase a cytotoxic T lymphocyte (CTL) response to an antigen. The method involves comparing the amino acid sequences of anti-idiotypic monoclonal antibodies with those of antigens to identify homologous regions and HLA binding motifs. The identified peptide sequences are useful for stimulating CTL responses, which can be critical in therapeutic applications.

Career Highlights

Throughout his career, Kawano has worked with various organizations, including Health Research, Inc. and the University of Texas System. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kawano has collaborated with notable colleagues such as Soldano Ferrone and Constantin G Ioannides. These partnerships have enriched his research and expanded the impact of his innovations in immunology.

Conclusion

Kouichiro Kawano's work in the identification and design of immunogenic peptides represents a significant advancement in immunology. His innovative methods have the potential to enhance immune responses and contribute to the development of effective therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…